Novel polyisoprenyl phosphates block phospholipase D and human neutrophil activation in vitro and murine peritoneal inflammation in vivo.
about
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorDesign and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificityDesign of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 productionEndogenous lipid mediators in the resolution of airway inflammationResolvins and protectins in inflammation resolution.Phospholipase D: enzymology, functionality, and chemical modulationRegulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury.Lipid mediators as agonists for the resolution of acute lung inflammation and injury.15-Epi-lipoxin A4 inhibits human neutrophil superoxide anion generation by regulating polyisoprenyl diphosphate phosphatase 1.Chemical mediators and the resolution of airway inflammationChemical modulation of glycerolipid signaling and metabolic pathways.Activation of polyisoprenyl diphosphate phosphatase 1 remodels cellular presqualene diphosphate.Identification and functional characterization of a presqualene diphosphate phosphatase.PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fc{gamma}-receptor-stimulated ROS production in neutrophils.
P2860
Q24635853-A8FAF766-C703-410F-B175-6AA512040516Q28237443-53EBC0D9-B373-4EBD-939A-AB8766BA144BQ33399066-49983C2A-4AAA-40F4-BABA-1D0C916654D4Q33810162-FDE831BC-014B-4452-9EF2-E2DDB4292613Q34058334-D0E6CE24-BC58-4723-94C9-225F285A8D6CQ34423359-9DA0B152-5043-43D7-9EDB-1BBD048EE26FQ35332873-9EC83502-349B-4324-9336-0CA9229E29BDQ35599714-6534B39F-3198-437B-A295-32FF33669E4CQ36228479-3218A5B5-4ADB-4FDD-AEE5-6DC508DDABD2Q36600802-6A54C9CB-F241-411B-8EC7-00DAF9C0CD31Q36945109-90412068-36BC-4C03-88DE-3CD73E39DAE4Q37306353-2DDFE405-6C91-4A06-B5B5-EB12674C09F1Q38179801-E00161D3-1194-4DB5-AD51-E279B131F874Q39883481-A5E5A620-0B17-47EB-857B-292FFA8980B7Q42428341-EA66DF02-B2EE-4E2B-89BE-FFFB67FD4C9CQ42741106-9245B39B-2933-45C2-95A9-EEF1A8A1D91D
P2860
Novel polyisoprenyl phosphates block phospholipase D and human neutrophil activation in vitro and murine peritoneal inflammation in vivo.
description
2005 nî lūn-bûn
@nan
2005 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@en
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@nl
type
label
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@en
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@nl
prefLabel
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@en
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@nl
P2093
P2860
P356
P1476
Novel polyisoprenyl phosphates ...... ritoneal inflammation in vivo.
@en
P2093
Andrew J Morris
Bruce D Levy
Charles N Serhan
Lorraine Hickey
Mykol Larvie
Raquel Keledjian
P2860
P304
P356
10.1038/SJ.BJP.0706338
P407
P577
2005-10-01T00:00:00Z